Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.
about
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesSynergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effectsThymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosisCharacterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretomeOsteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration.Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 productionIn vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma.Serum monocyte chemoattractant protein-1 in pancreatic cancer.A MCP1 fusokine with CCR2-specific tumoricidal activityRoles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancerAssessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patientsAnti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?Role of chemokines in tumor growth.MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts.Microarray-based understanding of normal and malignant plasma cells.Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma.Chemokines in multiple myelomaMonocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivoHigh expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection.Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors.CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.Tumor infiltrating regulatory T cells: tractable targets for immunotherapy.Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?Adipocyte-derived players in hematologic tumors: useful novel targets?Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.The effects of thalidomide on chemotactic migration of multiple myeloma cell lines.Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells.Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell-Derived Chemokine (C-C Motif) Ligand 2 and Chemokine (C-X-C motif) Ligand 1 Contributes to Neointima Formation.Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.Calcium receptor stimulates chemotaxis and secretion of MCP-1 in GnRH neurons in vitro: potential impact on reduced GnRH neuron population in CaR-null mice.Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor.Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.Crucial biological functions of CCL7 in cancer.
P2860
Q26866236-7C669E98-7E58-41B3-8071-4B036DCB661AQ28235478-FB594409-A31C-4176-AB5A-EA3D3B3CD629Q28476755-D0DA8A8A-2DFA-4541-8E60-2E329E0AB965Q30496213-6790EC6F-9614-4EB1-8A60-71EA018CECCDQ33564854-FB9A33CF-18E4-4492-88EF-5656F8057313Q33803085-45F8B121-0411-4DC6-8A70-6DE286069C76Q33986185-B5622DA2-81EB-42FD-8303-3964DD3B1ECAQ34501627-4588B9D9-BE46-43A4-A80B-97D6A0FCA98BQ34540657-B1E169CC-6D1E-4AAA-B50F-C958517DE989Q35251086-A716434E-D62B-4794-A467-40BF184549A4Q35299025-C6090621-6B53-430B-BC41-574AD74E1F7DQ35352078-39E12B55-6769-47D0-A987-C81D5E7DFE28Q35466987-68EB7202-6ECF-4774-9509-E6FB8B494329Q35696305-CB667D59-EC56-40A7-8277-930D92DC05C1Q35963125-D8DC88E5-4CB0-454A-BC2E-FB6F147CC336Q36120825-6B878593-6289-43AA-808A-A7F26B30C1DBQ36141697-1DA5DBAC-F53C-4825-8958-C25A66DE4F14Q36453354-53EBD885-2F2D-4A05-8875-407B44F7EED5Q36564495-6029EF4A-BD51-4A8C-B7EF-C96C9C9BFF7DQ36596949-65371942-ED8C-4DA5-9888-FAE45654150EQ37109532-FDC67ED3-5595-44D6-8765-E521DDDC559AQ37269169-C83837C4-BCCA-446E-8B49-0F676242263DQ37591986-87187A74-CE96-45C8-845D-B8184AA24574Q37694678-A3B90E79-C18C-48A9-BDE5-F4422AE1627FQ37788679-95FF219E-72CB-4893-A825-50F3C0E70734Q37809345-6309464D-2DBC-4744-9FB8-69A2DBF0760EQ37983913-52BA83F2-7895-4BDD-BEF3-F65E2650974EQ38259527-89E96F32-8396-418D-A98B-8C2B399262FFQ38736038-B2EB0C85-991F-4A68-A207-2E8847F0FBECQ38850981-F8AA2734-2065-49F1-8848-FA300C100945Q39982583-DA823D70-35AC-48FE-8CB1-04DEEF7FFDFEQ40438264-E6A1A8FB-CE7E-4BCA-9359-429E6ABC5716Q41109128-9911FDDC-6B83-4A78-8F10-EB07DDD64869Q41136953-128B4C35-67A8-457D-BA6E-3DAF28D471CFQ42501872-D4DB7834-5C1E-4A13-B3A7-431475D68448Q48004163-69249BE1-D8C1-43D4-A9FF-A86FF1B4E09BQ52718642-F72CBCFF-F10D-4778-B0B0-23EE4F706104Q55364341-52CF5745-AE5F-41A2-8BF0-8056CA719971
P2860
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Chemokine receptor CCR2 is exp ...... tic proteins MCP-1, -2 and -3.
@en
type
label
Chemokine receptor CCR2 is exp ...... tic proteins MCP-1, -2 and -3.
@en
prefLabel
Chemokine receptor CCR2 is exp ...... tic proteins MCP-1, -2 and -3.
@en
P2093
P2860
P356
P1476
Chemokine receptor CCR2 is exp ...... tic proteins MCP-1, -2 and -3.
@en
P2093
B Van Camp
I Van Riet
I Vande Broek
K Asosingh
K Vanderkerken
N Straetmans
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600833
P407
P577
2003-03-01T00:00:00Z
P5875
P6179
1048472361